The medical community and governments can no longer ignore the consequences of the promotion of medicines on prescribing.
Articles on Prescribing
Displaying 1 - 20 of 29 articles
From October 1, specially qualified nurses will be able to prescribe medications and renew scripts at the subsidised price.
Prescriptions for ADHD have grown 11-fold in 20 years. As GPs begin to prescribe ADHD medication, will this rise again?
After completing studies in prescribing, registered nurses will be able to prescribe a range of medicines – in collaboration with a doctor or nurse practitioner.
One in five people experience chronic pain. Here’s how likely you are to find relief with medicinal cannabis.
The core features of autism can’t and don’t need to be altered. But medications can help manage autistic people’s physical and mental health conditions.
60-day scrips can mean fewer trips to the pharmacist and lower costs. But only one in five eligible scripts are for a 60-day supply. Here’s what’s going wrong.
Too often, prescribing errors occur due to programming errors or poor design and have less to do with the health workers using the system.
Some IV fluids are in short supply due to higher-than-expected demand and manufacturing issues. But why do IV fluids contain different chemicals? And why can’t they be interchanged when one runs low?
We suspect these drug company payments are just the tip of the iceberg.
There is no legal duty to tell a patient they have been prescribed a drug ‘off label’.
Developing new antibiotics is important in the fight against antibiotic resistance. But we also need to use the antibiotics we already have much more wisely – GPs play a major role in this.
A new review of Australian health care workers’ scope of practice should focus on expanding pharmacists prescribing for stable conditions and long-term medications, under the direction of a GP.
The big news on budget night was a tripling of the bulk-billing incentive. It’s hoped to stem the decline in bulk billing – but it’s unclear if it will increase it.
Antipsychotics can have severe side effects, there’s a lack of guidance on how to stop taking these drugs safely.
As access to health care increases, there’s also a danger of getting too much of it.
Widely adopted in the US when pandemic precautions kept people home, telehealth faces a challenge as insurance coverage changes, right when its popularity had surged.
When news reports tout a drug, people get interested, even if the benefits are unproven. Patient hopes, requests and demands can easily turn into real prescriptions in their doctor’s office.
Taking tranquilizers with opioids increases the risk of overdose tenfold.
Prominent GP and former MP Kerryn Phelps has weighed into the doctor-pharmacist turf war, saying pharmacists shouldn’t prescribe because of their financial interests. But the evidence says otherwise.
Top contributors
-
Honorary Research Fellow, University of Bath
-
Senior Research Manager, University of Sydney and Honorary Assistant Professor, Bond University
-
Program Director, Health and Aged Care, Grattan Institute
-
Professor in Pharmaceutical Policy, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Professor and Dean School Nursing and Midwifery, La Trobe University
-
Professor of Public Health, Bond University
-
Research Fellow, Quality Use of Medicines and Pharmacy Research Centre, Adelaide University
-
Palliative Medicine Physician, Senior Research Fellow, The University of Melbourne
-
Associate, Health & Aged Care Program, Grattan Institute
-
Assistant Professor | NHMRC Emerging Leadership Fellow, Bond University
-
Assistant Professor of Public Health, Bond University
-
Post-Doctoral Research Fellow, University of Oxford
-
Honorary Enterprise Professor, School of Population and Global Health, and Department of General Practice and Primary Care, The University of Melbourne
-
Associate Professor of Health Policy, Management and Leadership, West Virginia University
-
Associate Professor in Pharmacy Practice and Digital Public Health, Kingston University